1. Home
  2. EVH vs WVE Comparison

EVH vs WVE Comparison

Compare EVH & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • WVE
  • Stock Information
  • Founded
  • EVH 2011
  • WVE 2012
  • Country
  • EVH United States
  • WVE Singapore
  • Employees
  • EVH N/A
  • WVE N/A
  • Industry
  • EVH Other Consumer Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVH Consumer Discretionary
  • WVE Health Care
  • Exchange
  • EVH Nasdaq
  • WVE Nasdaq
  • Market Cap
  • EVH 1.0B
  • WVE 915.6M
  • IPO Year
  • EVH 2015
  • WVE 2015
  • Fundamental
  • Price
  • EVH $4.29
  • WVE $7.60
  • Analyst Decision
  • EVH Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • EVH 14
  • WVE 12
  • Target Price
  • EVH $12.25
  • WVE $19.08
  • AVG Volume (30 Days)
  • EVH 5.5M
  • WVE 3.5M
  • Earning Date
  • EVH 11-06-2025
  • WVE 11-10-2025
  • Dividend Yield
  • EVH N/A
  • WVE N/A
  • EPS Growth
  • EVH N/A
  • WVE N/A
  • EPS
  • EVH N/A
  • WVE N/A
  • Revenue
  • EVH $2,054,052,000.00
  • WVE $109,230,000.00
  • Revenue This Year
  • EVH N/A
  • WVE N/A
  • Revenue Next Year
  • EVH $27.90
  • WVE $6.24
  • P/E Ratio
  • EVH N/A
  • WVE N/A
  • Revenue Growth
  • EVH N/A
  • WVE 103.75
  • 52 Week Low
  • EVH $3.50
  • WVE $5.28
  • 52 Week High
  • EVH $13.62
  • WVE $16.38
  • Technical
  • Relative Strength Index (RSI)
  • EVH 32.73
  • WVE 52.14
  • Support Level
  • EVH $3.60
  • WVE $6.60
  • Resistance Level
  • EVH $4.55
  • WVE $7.27
  • Average True Range (ATR)
  • EVH 0.48
  • WVE 0.54
  • MACD
  • EVH 0.07
  • WVE 0.03
  • Stochastic Oscillator
  • EVH 28.73
  • WVE 66.24

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: